181 related articles for article (PubMed ID: 30177679)
1. SCF
Huang LY; Zhao J; Chen H; Wan L; Inuzuka H; Guo J; Fu X; Zhai Y; Lu Z; Wang X; Han ZG; Sun Y; Wei W
Nat Commun; 2018 Sep; 9(1):3569. PubMed ID: 30177679
[TBL] [Abstract][Full Text] [Related]
2. Post-transcriptional regulation of BRG1 by FIRΔexon2 in gastric cancer.
Ailiken G; Kitamura K; Hoshino T; Satoh M; Tanaka N; Minamoto T; Rahmutulla B; Kobayashi S; Kano M; Tanaka T; Kaneda A; Nomura F; Matsubara H; Matsushita K
Oncogenesis; 2020 Feb; 9(2):26. PubMed ID: 32071290
[TBL] [Abstract][Full Text] [Related]
3. FBW7 regulates DNA interstrand cross-link repair by modulating FAAP20 degradation.
Wang J; Jo U; Joo SY; Kim H
Oncotarget; 2016 Jun; 7(24):35724-35740. PubMed ID: 27232758
[TBL] [Abstract][Full Text] [Related]
4. Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas.
Sentani K; Oue N; Kondo H; Kuraoka K; Motoshita J; Ito R; Yokozaki H; Yasui W
Pathobiology; 2001; 69(6):315-20. PubMed ID: 12324708
[TBL] [Abstract][Full Text] [Related]
5. FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
Zhang Y; Zhang X; Ye M; Jing P; Xiong J; Han Z; Kong J; Li M; Lai X; Chang N; Zhang J; Zhang J
Cancer Lett; 2018 Apr; 419():75-83. PubMed ID: 29355657
[TBL] [Abstract][Full Text] [Related]
6. FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis.
Li Q; Li Y; Li J; Ma Y; Dai W; Mo S; Xu Y; Li X; Cai S
Int J Biol Sci; 2018; 14(7):726-735. PubMed ID: 29910683
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
Medina PP; Sanchez-Cespedes M
Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
[TBL] [Abstract][Full Text] [Related]
8. Physiological functions of FBW7 in cancer and metabolism.
Shimizu K; Nihira NT; Inuzuka H; Wei W
Cell Signal; 2018 Jun; 46():15-22. PubMed ID: 29474981
[TBL] [Abstract][Full Text] [Related]
9. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1.
Sánchez-Tilló E; Lázaro A; Torrent R; Cuatrecasas M; Vaquero EC; Castells A; Engel P; Postigo A
Oncogene; 2010 Jun; 29(24):3490-500. PubMed ID: 20418909
[TBL] [Abstract][Full Text] [Related]
10. BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer.
Zhu X; Sun L; Lan J; Xu L; Zhang M; Luo X; Gong J; Wang G; Yuan X; Hu J; Wang J
Oncotarget; 2016 Jun; 7(24):36501-36509. PubMed ID: 27145366
[TBL] [Abstract][Full Text] [Related]
11. Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.
Saladi SV; Keenen B; Marathe HG; Qi H; Chin KV; de la Serna IL
Mol Cancer; 2010 Oct; 9():280. PubMed ID: 20969766
[TBL] [Abstract][Full Text] [Related]
12. Proteasomal degradation of the tumour suppressor FBW7 requires branched ubiquitylation by TRIP12.
Khan OM; Almagro J; Nelson JK; Horswell S; Encheva V; Keyan KS; Clurman BE; Snijders AP; Behrens A
Nat Commun; 2021 Apr; 12(1):2043. PubMed ID: 33824312
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.
Kumar Y; Shukla N; Thacker G; Kapoor I; Lochab S; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
Mol Cancer Res; 2016 Nov; 14(11):1097-1109. PubMed ID: 27470268
[TBL] [Abstract][Full Text] [Related]
14. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
15. Evf2 lncRNA/BRG1/DLX1 interactions reveal RNA-dependent inhibition of chromatin remodeling.
Cajigas I; Leib DE; Cochrane J; Luo H; Swyter KR; Chen S; Clark BS; Thompson J; Yates JR; Kingston RE; Kohtz JD
Development; 2015 Aug; 142(15):2641-52. PubMed ID: 26138476
[TBL] [Abstract][Full Text] [Related]
16. FBW7 suppresses ovarian cancer development by targeting the N
Xu F; Li J; Ni M; Cheng J; Zhao H; Wang S; Zhou X; Wu X
Mol Cancer; 2021 Mar; 20(1):45. PubMed ID: 33658012
[TBL] [Abstract][Full Text] [Related]
17. The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer.
Wu Q; Lian JB; Stein JL; Stein GS; Nickerson JA; Imbalzano AN
Epigenomics; 2017 Jun; 9(6):919-931. PubMed ID: 28521512
[TBL] [Abstract][Full Text] [Related]
18. FBW7 targets KLF10 for ubiquitin-dependent degradation.
Yu S; Wang F; Tan X; Gao GL; Pan WJ; Luan Y; Ge X
Biochem Biophys Res Commun; 2018 Jan; 495(2):2092-2097. PubMed ID: 29198712
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
20. FBW7 suppresses cell proliferation and G2/M cell cycle transition via promoting γ-catenin K63-linked ubiquitylation.
Li Y; Hu K; Xiao X; Wu W; Yan H; Chen H; Chen Z; Yin D
Biochem Biophys Res Commun; 2018 Mar; 497(2):473-479. PubMed ID: 29408378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
